Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 MRD at the end of induction therapy in childhood acute lymphoblastic leukemia: outcome prediction strongly depends on the therapeutic regimen.

× No keyword cloud information.

7 in total

Review 1. The clinical relevance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia.

Authors: J Moppett; G A A Burke; C G Steward; A Oakhill; N J Goulden
Journal: J Clin Pathol Date: 2003-04 Impact factor: 3.411

Review 2. Treatment of pediatric acute lymphoblastic leukemia: progress achieved and challenges remaining.

Authors: Paul S Gaynon
Journal: Curr Hematol Malig Rep Date: 2007-07 Impact factor: 3.952

3. The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97).

Authors: Gabriele Escherich; Anja Tröger; Ulrich Göbel; Ulrike Graubner; Arnulf Pekrun; Norbert Jorch; Gjl Kaspers; Martin Zimmermann; Udo zur Stadt; Karin Kazemier; Rob Pieters; Monique L Den Boer; Martin Horstmann; Gritta E Janka
Journal: Haematologica Date: 2011-02-17 Impact factor: 9.941

4. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.

Authors: Michael J Borowitz; Meenakshi Devidas; Stephen P Hunger; W Paul Bowman; Andrew J Carroll; William L Carroll; Stephen Linda; Paul L Martin; D Jeanette Pullen; David Viswanatha; Cheryl L Willman; Naomi Winick; Bruce M Camitta
Journal: Blood Date: 2008-04-03 Impact factor: 22.113

MRD at the end of induction therapy in childhood acute lymphoblastic leukemia: outcome prediction strongly depends on the therapeutic regimen.

Review 1. The clinical relevance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia.

Review 2. Treatment of pediatric acute lymphoblastic leukemia: progress achieved and challenges remaining.

3. The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97).

4. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.

5. Improved outcome in childhood ALL with intensive consolidation and hematopoietic stem cell transplant.

Review 6. Minimal Residual Disease Evaluation in Childhood Acute Lymphoblastic Leukemia: A Clinical Evidence Review.

7. Prognostic factors in childhood acute lymphoblastic leukemia.